XM does not provide services to residents of the United States of America.
On 4th March this year, XM revisited the City of Manila in the Philippines with a free seminar for online investors on the use of technical analysis in CFD trading.
Providing free trading seminars throughout Southeast Asia has been a significant part of the XM educational program for several years now, including the Philippines, where the latest such event took place in the Filipino capital.
Organized at Dusit Thani Manila Hotel, the seminar was presented by Jonathan Lou Reyes, who initiated participants into all details relevant to trading multiple financial instruments as CFDs on the MT5 platform of XM. As Contracts for Difference are a powerful and flexible tool to invest in multiple financial instruments, event guests could get to know many useful details about short-term vs long-term trading strategies, including the use of technical analysis to tap into price action.
Apart from an overview of the global CFD markets, Jonathan Lou Reyes dedicated much time to techniques when it comes to investing in individual stocks, stock indices, precious metals and energies, with special respect to the use of the Moving Average Ribbon technique, which helps investors follow market movements and know when to enter or exit the markets.
The seminar concluded with an XM lucky draw, where the names of all those were raffled who took part in the event and whom we would like to congratulate once again on their prizes.
Lucky Draw Winners
Prizes | MT4/MT5 Account ID |
---|---|
Prize 1: Phone Huawei Y7 Prime 32GB | 3029658 |
Prize 2: Phone Huawei Mate 10 64GB | 34045987 |
Prize 3: Apple iPad 9.7 Wi-Fi 32GB | 14005284 |
We would like to express our special thanks to every existing and new client of ours who attended the free seminar in Manila, and we hope that the syllabus presented will be useful for them to further improve their trading practices.
Registrations are already open for our new seminar series coming up in two Filipino cities this spring, the details of which can be viewed here.
Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.